Cargando…

Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial

BACKGROUND: Venous thromboembolism (VTE) and deep vein thrombophlebitis (DVT) is a serious problem with high mortality and morbidity rates. This study was conducted to compare efficacy and safety results of the two types of VTE preventing in patients underwent total knee arthroplasty (TKA). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirdamadi, Ahmad, Dashtkar, Solmaz, Kaji, Mahboobeh, Pazhang, Farzad, Haghpanah, Behnam, Gharipour, Mojgan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354081/ https://www.ncbi.nlm.nih.gov/pubmed/25815018

Ejemplares similares

Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis
por: Huang, Hai-Feng, et al.
Publicado: (2018)

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials
por: Eriksson, Bengt I., et al.
Publicado: (2015)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
por: Levitan, Bennett, et al.
Publicado: (2014)

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty
por: Simon, Samantha J., et al.
Publicado: (2023)

Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
por: Woo, Hee Doo, et al.
Publicado: (2013)

Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
por: Fuji, Takeshi, et al.
Publicado: (2015)

Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019)

Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA)
por: van Veen, Lucia, et al.
Publicado: (2013)

Venous thromboembolism after total knee and hip arthroplasty: A retrospective study
por: Almegren, Mosaad O., et al.
Publicado: (2018)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
por: Baker, Kevin, et al.
Publicado: (2017)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons
por: Kim, Nam Ki, et al.
Publicado: (2016)

Enoxaparin-induced skin necrosis at injection site after total knee arthroplasty
por: Haffner, Max, et al.
Publicado: (2017)

The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013)

Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran
por: Abutorabi, Ali, et al.
Publicado: (2023)

Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia
por: Brandão, Leonardo R., et al.
Publicado: (2022)

Unicompartmental knee arthroplasty and revision total knee arthroplasty have a lower risk of venous thromboembolism disease at 30 days than primary total knee arthroplasty
por: Schneider, Andrew M., et al.
Publicado: (2020)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
por: Roman, Francisco, et al.
Publicado: (2018)

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban()
por: Colleoni, Jose Luiz, et al.
Publicado: (2017)

Venous Thromboembolism Prevention Protocol: Experience of 2,000 Cases in Total Knee Arthroplasty*
por: Carvalho Júnior, Lúcio Honório de, et al.
Publicado: (2020)

Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events After Total Knee Arthroplasty
por: Bala, Abiram, et al.
Publicado: (2021)

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
por: Dybdahl, Daniel, et al.
Publicado: (2019)

Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials
por: Kawai, Yohko, et al.
Publicado: (2016)

Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years
por: Zhang, Zi-hao, et al.
Publicado: (2015)

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
por: Gómez-Outes, Antonio, et al.
Publicado: (2012)

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
por: Çiçek, Necati, et al.
Publicado: (2021)

Risk factors for venous thromboembolism in total shoulder arthroplasty
por: Lung, Brandon E., et al.
Publicado: (2019)

Rivaroxaban and Acetylsalicylic Acid for Prevention of Venous Thromboembolism Following Total Knee Arthroplasty in Korean Patients
por: Chung, Kyu Sung, et al.
Publicado: (2018)

Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin versus warfarin
por: Goel, R., et al.
Publicado: (2018)

Low relative muscle volume: Correlation with prevalence of venous thromboembolism following total knee arthroplasty
por: Shin, Jung-Min, et al.
Publicado: (2019)

Effect of tranexamic acid on symptomatic venous thromboembolism in patients undergoing primary total knee arthroplasty
por: Peng, Huiming, et al.
Publicado: (2020)

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
por: Clemens, Andreas, et al.
Publicado: (2012)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement
por: Dranitsaris, George, et al.
Publicado: (2011)

Current and emerging strategies in the management of venous thromboembolism: benefit–risk assessment of dabigatran
por: Fanola, Christina L
Publicado: (2015)

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
por: Leung, Timothy S, et al.
Publicado: (2015)

System Dynamics to Model the Unintended Consequences of Denying Payment for Venous Thromboembolism after Total Knee Arthroplasty
por: Worni, Mathias, et al.
Publicado: (2012)

Reduction of the incidence of development of venous thromboembolism by ultrasound-guided femoral nerve block in total knee arthroplasty
por: Asakura, Yusuke, et al.
Publicado: (2011)

Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
por: Akamine, Akihiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v7o3dkdcd71bjb7ocmjpapuj5m